Market Tracker

10/23 6:05pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

22.65
Data as of Oct 23
 +0.44 / +1.98%
Today’s Change
9.71
Today|||52-Week Range
23.31
+124.70%
Year-to-Date

Today’s Trading

Previous close22.21
Today’s open22.36
Day’s range22.36 - 22.97
Volume227,791
Average volume (3 months)300,891
Market cap$721.3M
Dividend yield--
Data as of 3:59pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+25.71%
Earnings growth (next 5 years)+19.70%
Revenue growth (last year)+8.77%
P/E ratio45.3
Price/Sales1.26
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...+0.91+8.80%
LXRXLexicon Pharmaceutic...+0.02+1.48%
BRLIBio-Reference Labora...+0.42+1.46%
NXTMNxStage Medical Inc+0.14+0.97%
Data as of 4:14pm ET, 10/23/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)$0.16
Annual revenue (last year)$246.6M
Annual profit (last year)$12.7M
Net profit margin5.14%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
SVP
Michael Nolan
Corporate headquarters
Albany, New York

Forecasts